Department of Medical, Surgical, Neurological, Metabolic Sciences, and Aging, 2nd Division of Neurology, Center for Rare Diseases and InterUniversity Center for Research in Neurosciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy; Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA.
Biochem Pharmacol. 2018 Aug;154:303-317. doi: 10.1016/j.bcp.2018.05.016. Epub 2018 May 24.
Neurodegenerative diseases (NDs) and brain tumors are severe, disabling, and incurable disorders that represent a critical problem regarding human suffering and the economic burden on the healthcare system. Because of the lack of effective therapies to treat NDs and brain tumors, the challenge for physicians is to discover new drugs to improve their patients' quality of life. In addition to risk factors such as genetics and environmental influences, increased cellular oxidative stress has been reported as one of the potential common etiologies in both disorders. Given their antioxidant and anti-inflammatory potential, dietary polyphenols are considered to be one of the most bioactive natural agents in chronic disease prevention and treatment. Despite the protective activity of polyphenols, their inefficient delivery systems and poor bioavailability strongly limit their use in medicine and functional food. A potential solution lies in polymeric nanoparticle-based polyphenol delivery systems that are able to enhance their absorption across the gastrointestinal tract, improve their bioavailability, and transport them to target organs. In the present manuscript, we provide an overview of the primary polyphenols used for ND and brain tumor prevention and treatment by focusing on recent findings, the principal factors limiting their application in clinical practice, and a promising delivery strategy to improve their bioavailability.
神经退行性疾病(NDs)和脑肿瘤是严重、致残和无法治愈的疾病,它们给人类带来痛苦并给医疗保健系统带来了巨大的经济负担,是一个严重的问题。由于缺乏有效的治疗神经退行性疾病和脑肿瘤的方法,医生的挑战在于发现新的药物来提高患者的生活质量。除了遗传和环境等风险因素外,细胞氧化应激增加也被认为是这两种疾病的潜在共同病因之一。鉴于其抗氧化和抗炎潜力,膳食多酚被认为是预防和治疗慢性疾病的最具生物活性的天然药物之一。尽管多酚具有保护作用,但它们低效的传递系统和较差的生物利用度严重限制了它们在医学和功能性食品中的应用。一种潜在的解决方案在于基于聚合物纳米粒子的多酚传递系统,它能够增强多酚在胃肠道中的吸收,提高其生物利用度,并将其输送到靶器官。在本手稿中,我们通过关注最近的发现、限制其在临床实践中应用的主要因素以及提高其生物利用度的有前途的传递策略,概述了用于预防和治疗 NDs 和脑肿瘤的主要多酚。